NCT04618874View on ClinicalTrials.gov

US NAB With ROSE Versus US FNAB With no ROSE

NACompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

May 31, 2022

Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST

Rapid on-site evaluation

Rapid on site evaluation performed with an MGG quick stain (Bio-Optica, Milano, Italy).

Trial Locations (1)

Unknown

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT04618874 - US NAB With ROSE Versus US FNAB With no ROSE | Biotech Hunter | Biotech Hunter